Collegium Q2 2026 Earnings: Acquisition Costs Push GAAP Results Into a LossTradingKey·7 hours agoCOLL-1855.00%
Collegium turns to GAAP net loss of $15.1 million in Q2 FY26; revenue rises 6% to $199.9 millionPUBT·8 hours agoCOLL-1855.00%
Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company ProgressUnusual Whales·8 hours agoCOLL-1855.00%
Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To ExpectStock Story·1 day ago, 10:36 PMCOLL-1855.00%
Collegium Pharmaceutical to report Q2 2026 results, host earnings callPUBT·Jul 23 at 07:05 AMCOLL-1855.00%
Collegium Pharma To Relocate Corporate Headquarters To Downtown Boston In 2027rttnews·Jul 20 at 09:31 AMCOLL-1855.00%
DivcoWest Welcomes Collegium Pharmaceutical to One LincolnUnusual Whales·Jul 20 at 07:47 AMCOLL-1855.00%
Collegium Pharmaceutical (COLL) Stock Looks Fairly Valued With Strong Returns But Mixed Earnings##Simplywall·Jul 18 at 12:10 AMCOLL-1855.00%
As Q2 earnings kick off, these small-cap stocks earn an A+ for profitabilityMSN·Jul 17 at 12:21 PMCNNE-34.00%BLKB+102.00%
Navigating Late-Cycle Cross-Currents: From Crypto Casualties to Sector Consolidation Amid Resurgent VolatilityGlobal Report·Jul 9 at 09:02 PMTTD-680.00%ASTC-110.00%
Biotech and CXO Clinical Momentum: 7 Core Companies Set for Late-2026 BreakoutsGlobal Report·Jul 9 at 05:02 AMBVS-839.00%ALT-66.00%
Stop Pitching AI and Gene Therapy. Which Biotechs Are Actually Delivering?Global Report·Jul 8 at 10:32 PMTEM-124.00%PACB-1038.00%
Is Collegium Pharmaceutical (COLL) A Bargain On Its Azstarys Deal And 2026 Guidance?Simplywall·Jul 3 at 03:12 PMCOLL-1855.00%
